r.kirchner
Submits third-party assay reports on material purchased directly. Based in Osijek.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
9
n=9
Annotations
0
n=0
Median purity submitted
99.02%
n=9
Suppliers covered
7
n=9
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041434 | Retatrutide | QYB | QYB-2604-B4920 | Medutest | 2026-Q3 | 99.02 | 2.65 | 96.9 | Laboratory-retained | 0 | PASS |
| AX-2026-042089 | MOTS-c | HYB | HYB-2606-D7858 | Medutest | 2026-Q3 | 99.38 | 2.65 | — | Buyer-sourced | 0 | PASS |
| AX-2026-043332 | BPC-157 | CPC | CPC-2601-M1478 | Janoshik | 2026-Q2 | 98.71 | 6.15 | — | Supplier-supplied | 0 | PASS |
| AX-2026-042030 | SS-31 (Elamipretide) | HYB | HYB-2512-B6579 | Janoshik | 2026-Q2 | 99.93 | 1.41 | 98.8 | Buyer-sourced | 0 | PASS |
| AX-2026-041938 | Semax | SinoPep | SNP-2601-U4736 | Janoshik | 2026-Q1 | 99.49 | 7.21 | 96.9 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-018481 | CJC-1295 with DAC | WWB | WWB-2509-J2816 | Kestrel | 2025-Q4 | 98.99 | 3.47 | — | Buyer-sourced | 1 | FAIL |
| AX-2025-018968 | Tirzepatide | ASY | ASY-{CAT}-1787 | Janoshik | 2025-Q2 | 98.44 | 3.34 | — | Buyer-sourced | 0 | PASS |
| AX-2025-018516 | Semaglutide | WWB | WWB-2410-J3284 | Janoshik | 2025-Q1 | 99.55 | 3.46 | 105.1 | Buyer-sourced | 0 | PASS |
| AX-2024-004939 | NAD+ | GGPeps | GGPE-2405-A3279 | VendorInvestigate | 2024-Q4 | 98.39 | 8.19 | 107.2 | Buyer-sourced | 0 | PASS |